World's Best Scientists 2026 revealed!
Robert L. Schlossman

Robert L. Schlossman

D-Index & Metrics

Medicine

D-Index
86
Citations
29749
World Ranking
14040
National Ranking
7122

Overview

Robert L. Schlossman is affiliated with Harvard University in the United States and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research primarily focuses on hematology, molecular biology, and oncology, with a notable emphasis on multiple myeloma research and treatments.

The scientist's work covers several specialized topics including:

  • Multiple Myeloma Research and Treatments
  • Cancer Treatment and Pharmacology
  • Protein Degradation and Inhibitors
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Ubiquitin and proteasome pathways
  • Histone Deacetylase Inhibitors Research

Among the recent scholarly articles involving Robert L. Schlossman are:

  • Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma (2022), New England Journal of Medicine
  • Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant (2020), Nature Communications
  • Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins (2021), Cell Reports
  • Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma (2022), Leukemia & lymphoma/Leukemia and lymphoma
  • Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma (2024), Blood Advances

The venues in which these works have been published include:

  • New England Journal of Medicine
  • Nature Communications
  • Cell Reports
  • Leukemia & lymphoma/Leukemia and lymphoma
  • Blood Advances

Robert L. Schlossman has collaborated frequently with several researchers, including:

  • Paul G. Richardson
  • Jacob P. Laubach
  • Kenneth C. Anderson
  • Nikhil C. Munshi
  • Giada Bianchi

Best Publications

  • Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy.

    Teru Hideshima;Dharminder Chauhan;Dharminder Chauhan;Yoshihito Shima;Yoshihito Shima;Noopur Raje;Noopur Raje

  • Lenalidomide after stem-cell transplantation for multiple myeloma

    Philip L. McCarthy;Kouros Owzar;Craig C. Hofmeister;David D. Hurd

  • Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.

    Faith E. Davies;Noopur Raje;Noopur Raje;Noopur Raje;Teru Hideshima;Teru Hideshima;Teru Hideshima;Suzanne Lentzsch;Suzanne Lentzsch;Suzanne Lentzsch

  • Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

    Paul G. Richardson;Robert L. Schlossman;Robert L. Schlossman;Edie Weller;Edie Weller;Teru Hideshima;Teru Hideshima

  • Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

    Paul G. Richardson;Edie Weller;Sagar Lonial;Andrzej J. Jakubowiak

  • Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

    Jesús F. San-Miguel;Vânia T.M. Hungria;Sung Soo Yoon;Meral Beksac

  • The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications.

    Nicholas Mitsiades;Constantine S. Mitsiades;Paul G. Richardson;Vassiliki Poulaki

  • Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.

    D Gupta;S P Treon;Y Shima;T Hideshima

  • Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

    Teru Hideshima;Constantine Mitsiades;Masaharu Akiyama;Toshiaki Hayashi

  • A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

    Paul G. Richardson;Emily Blood;Constantine S. Mitsiades;Sundar Jagannath

  • Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.

    Constantine S Mitsiades;Nicholas Mitsiades;Vassiliki Poulaki;Robert Schlossman

  • The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications.

    Teru Hideshima;Dharminder Chauhan;Robert Schlossman;Paul Richardson

  • IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.

    A Ogata;D Chauhan;G Teoh;S P Treon

  • TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

    Constantine S. Mitsiades;Steven P. Treon;Nicholas Mitsiades;Yoshihito Shima

  • Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma

    Arnold S. Freedman;Donna Neuberg;Peter Mauch;Robert J. Soiffer

  • Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant

    Edwin P. Alyea;Robert J. Soiffer;Christine Canning;Donna Neuberg

  • Molecular sequelae of histone deacetylase inhibition in human malignant B cells

    Nicholas Mitsiades;Constantine S. Mitsiades;Paul G. Richardson;Ciaran McMullan

  • Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity

    Douglas W McMillin;Jake Delmore;Jake Delmore;Ellen Weisberg;Ellen Weisberg;Joseph M Negri;Joseph M Negri

  • Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy

    Paul G. Richardson;Wanling Xie;Constantine Mitsiades;Asher A. Chanan-Khan

  • Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study

    Asher A. Chanan-Khan;Jonathan L. Kaufman;Jayesh Mehta;Paul G. Richardson

Frequent Co-Authors

Paul G. Richardson
Paul G. Richardson Harvard University
Nikhil C. Munshi
Nikhil C. Munshi Harvard University
Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Teru Hideshima
Teru Hideshima Harvard University
Irene M. Ghobrial
Irene M. Ghobrial Harvard University
Constantine S. Mitsiades
Constantine S. Mitsiades Harvard University
Noopur Raje
Noopur Raje Harvard University
Dharminder Chauhan
Dharminder Chauhan Harvard University
Sagar Lonial
Sagar Lonial Emory University
Yu-Tzu Tai
Yu-Tzu Tai Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in alternative healthcare careers or looking for flexible online learning options, there are several paths to consider alongside studying Medicine in the USA. For those holding a non-nursing bachelor’s degree, exploring non nursing bachelor's to msn online programs can provide a fast track into advanced nursing roles.

Prospective nurses in search of accessible programs may want to look into easy nursing schools to get into, which often have less competitive admissions processes. In addition, candidates who prefer to skip entrance exams should consider a nursing school without teas test as a straightforward entry route.

For those interested in healthcare administration, online training options for medical billing and coding are growing rapidly. Check out accredited medical billing and coding schools online with financial aid for flexible, career-focused programs. These related pathways offer a variety of opportunities in the healthcare sector beyond traditional medical degrees.

Best Scientists Citing Robert L. Schlossman

Trending Scientists

Recently Published Articles